Business

Announcement on the Renewal of Company Product Albuvirtide for Injection for Inclusion in the Catalogue of Drugs for Basic National Medical Insurance

Announcement on the Renewal of Company Product Albuvirtide for Injection for Inclusion in the Catalogue of Drugs for Basic National Medical Insurance

articleFrontier Biotechnologies Inc. Class ANovember 28, 20244/news/announcement-on-the-renewal-of-company-product-albuvirtide-for-injection-for-inclusion-in-the-catalogue-of-drugs-for-basic-national-medical-insurance
Announcement on the Renewal of Company Product Albuvirtide for Injection for Inclusion in the Catalogue of Drugs for Basic National Medical Insurance

About this update from Frontier Biotechnologies Inc. Class A

Announcement on the Renewal of Company Product Albuvirtide for Injection for Inclusion in the Catalogue of Drugs for Basic National Medical InsuranceThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Frontier Biotechnologies Inc. Class A